Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.

1st Department of Family Medicine Medical University of Lodz Poland

Agency for Social Services and Dependency Regional Government for Equality Social Policies and Conciliation of Andalucia Seville Spain

Allergist La Rochelle France

Allergist Mexico City Mexico

Allergist Montevideo Uruguay

Allergist Reims France

Allergy and Asthma Associates of Southern California Mission Viejo CA USA

Allergy and Asthma Center Westend Berlin Germany

Allergy and Asthma Medical Group and Research Center San Diego CA USA

Allergy and Asthma Unit Hospital San Bernardo Salta Salta Argentina

Allergy and Clinical Immunology Department Centro Médico Docente la Trinidad and Clínica El Avila Caracas Venezuela

Allergy and Clinical Immunology Section National Heart and Lung Institute Imperial College London London UK

Allergy and Clinical Immunology Unit Institute of Immunology Faculty of Medicine University of Coimbra ICBR Coimbra Institute for Clinical and Biomedical Research CIBB Coimbra Portugal

Allergy and Immunology Laboratory Metropolitan University Simon Bolivar University Barranquilla Colombia and SLaai Sociedad Latinoamericana de Allergia Asma e Immunologia Branquilla Colombia

Allergy and Respiratory Diseases Ospedale Policlino San Martino University of Genoa Genoa Italy

Allergy Center CUF Descobertas Hospital Lisbon Portugal

Allergy Department 2nd Pediatric Clinic Athens General Children's Hospital P and A Kyriakou University of Athens Athens Greece

Allergy Department Athens Naval Hospital Athens Greece

Allergy Section Department of Internal Medicine Hospital Vall d'Hebron and ARADyAL research network Barcelona Spain

Allergy Unit D Kalogeromitros 2nd Department of Dermatology and Venereology National and Kapodistrian University of Athens Attikon University Hospital Chaidari Greece

Allergy Unit Department of Dermatology University Hospital of Zurich Zürich Switzerland

Allergy Unit Presidio Columbus Rome Catholic University of Sacred Heart Rome and IRCCS Oasi Maria SS Troina Italy

Argentine Association of Allergy and Clinical Immunology Buenos Aires Argentina

ASA Advanced Solutions Accelerator Clapiers France

Assitant Director General Montpellier Région Occitanie Montpellier France

Association Asthme et Allergie Paris France

Association of Finnish Pharmacists Helsinki Finland

Asthma Reference Center School of Medicine of Santa Casa de Misericordia of Vitoria Esperito Santo Vitoria Brazil

Asthma UK London UK

Bull DSAS Echirolles France

Cáritas Diocesana de Coimbra Coimbra Portugal EIP AHA Reference Site Coimbra Portugal

Center for Rhinology and Allergology Wiesbaden Germany

Center of Allergy and Immunology Georgian Association of Allergology and Clinical Immunology Tbilisi Georgia

Center of Excellence in Asthma and Allergy Médica Sur Clinical Foundation and Hospital México City Mexico

Centich Centre d'Expertise National des Technologies de l'Information et de la communication pour l'autonomie Groupe VyV Conseil Régional des Pays de la Loire Centre d'expertise PartenariatEuropéen d'Innovation pour un vieillissement actif et en bonne santé Nantes France

Centre for Clinical Research Sörmland Uppsala University Eskilstuna Sweden

Centre for Empowering Patients and Communities Faulkland UK

Centre for Respiratory Medicine and Allergy Institute of Inflammation and Repair University of Manchester and University Hospital of South Manchester Manchester UK

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle Ouagadougou Burkina Faso

Centre Hospitalier Valenciennes Valenciennes France

Chachava Clinic David Tvildiani Medical University AIETI Medical School Grigol Robakidze University Tbilisi Georgia

Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt Uniersität zu Berlin and Berlin Institute of Health Comprehensive Allergy Centre Department of Dermatology and Allergy Member of GA2LEN Berlin Germany

Children's Hospital Srebrnjak Zagreb School of Medicine University JJ Strossmayer Osijek Croatia

CHU Clermont Ferrand Unité d'allergologie de l'enfant pôle pédiatrique Hôpital Estaing Clermont Ferrand France

CHU Dijon Dijon France

CIBER Epidemiología y Salud Pública Barcelona Spain

CINTESIS Center for Research in Health Technology and Information Systems Faculdade de Medicina da Universidade do Porto; and Medida Lda Porto Portugal

CIRFF Federico 2 University Naples Italy

Clinic for Pulmonary Diseases Clinical Center of Serbia Faculty of Medicine University of Belgrade Serbian Association for Asthma and COPD Belgrade Serbia

Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania

Clinic of Infectious Chest Diseases Dermatology and Allergology Vilnius University Vilnius Lithuania

Clinical Research Center for Allergy and Rheumatology Sagamihara National Hospital Sagamihara Japan

Coimbra Institute for Clinical and Biomedical Research Faculty of Medicine University of Coimbra; Coimbra and EIP AHA Reference Site Coimbra Portugal

Col Jardines de Sta Monica Tlalnepantla Mexico

Conseil Général de l'Economie Ministère de l'Economie de l'Industrie et du Numérique Paris France

CRI Clinical Research International Ltd Hamburg Germany

Croatian Pulmonary Society Zagreb Croatia

Cyprus International Institute for Environmental and Public Health in Association with Harvard School of Public Health Cyprus University of Technology Limassol Cyprus; Department of Pediatrics Hospital Archbishop Makarios 3 Nicosia Cyprus

Danish Committee for Health Education Copenhagen East Denmark

David Hide Centre St Mary's Hospital Isle of Wight and University of Southampton Southampton UK

Department of Advanced Biomedical Sciences Federico 2 University Napoli Italy

Department of Allergology Medical University of Gdańsk Gdansk Poland

Department of Allergology Medical University of Gdańsk Gdańsk Poland

Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon South Korea

Department of Allergy and Immunology Hospital Quirón Bizkaia Erandio Spain

Department of Allergy Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne Vic Australia; Department of Immunology Monash University Melbourne Vic Australia

Department of Biochemistry and Clinical Chemistry Faculty of Pharmacy with the Division of Laboratory Medicine Warsaw Medical University Warsaw Poland

Department of Chest Medicine Centre Hospitalier Universitaire UCL Namur Université Catholique de Louvain Yvoir Belgium

Department of Clinical Immunology Wrocław Medical University and ALL MED Medical Research Institute Warsaw Poland

Department of Clinical Pharmacy of Lithuanian University of Health Kaunas Lithuania

Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm and Sach's Children and Youth Hospital Södersjukhuset Stockholm Sweden

Department of Comparative Medicine Messerli Research Institute of the University of Veterinary Medicine and Medical University Vienna Austria

Department of Dermatology and Allergy Centre Odense University Hospital Odense Research Center for Anaphylaxis Odense Denmark

Department of General ORL H and NS Medical University of Graz Graz Austria

Department of Geriatrics Montpellier University hospital Montpellier France

Department of Health Research Methods Evidence and Impact Division of Immunology and Allergy McMaster University Hamilton ON Canada

Department of Health Social Services and Public Safety Northern Ireland Belfast UK

Department of Immunology and Allergology Faculty of Medicine in Pilsen Charles University Prague Pilsen Czech Republic

Department of Immunology and Allergy Healthy Ageing Research Center Medical University of Lodz Lodz Poland

Department of Internal Medicine and Allergy Clinic of Professor Polydoro Ernani de São Thiago University Hospital Federal University of Santa Catarina Florianopolis SC Brazil

Department of Internal Medicine Medical University of Graz Graz Austria

Department of Lung Diseases and Clinical Immunology University of Turku and Terveystalo Allergy Clinic Turku Finland

Department of Medical Sciences Allergy and Clinical Immunology Unit University of Torino and Mauriziano Hospital Torino Italy

Department of Medicine Bon Secours Hospital Glasnevin Dublin Ireland

Department of Medicine Clinical Immunology and Allergy McMaster University Hamilton ON Canada

Department of Medicine Surgery and Dentistry Scuola Medica Salernitana University of Salerno Salerno Italy

Department of Medicine University of Cape Town Cape Town South Africa

Department of Nephrology and Endocrinology Karolinska University Hospital Stockholm Sweden

Department of Otolaryngology Head and Neck Surgery Beijing TongRen Hospital and Beijing Institute of Otolaryngology Beijing China

Department of Otolaryngology Head and Neck Surgery University of Mainz Mainz Germany

Department of Otolaryngology Nippon Medical School Tokyo Japan

Department of Otolaryngology Yong Loo Lin School of Medicine National University of Singapore Singapore City Singapore

Department of Otorhinolaryngology Academic Medical Centres AMC Amsterdam the Netherlands and Euforea Brussels Belgium

Department of Otorhinolaryngology Head and Neck Surgery Section of Rhinology and Allergy University Hospital Marburg Philipps Universität Marburg Marburg Germany

Department of Otorhinolaryngology HNO Klinik Universitätsklinikum Düsseldorf Düsseldorf Germany

Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece

Department of Paediatrics and Child Health Red Cross Children's Hospital and MRC Unit on Child and Adolescent Health University of Cape Town Cape Town South Africa

Department of Paediatrics Prince of Wales Hospital The Chinese University of Hong Kong Shatin New Territories Hong Kong China

Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil

Department of Pediatrics Nippon Medical School Tokyo Japan

Department of Physical Pharmacy and Bioanalysis Faculty of Pharmacy with the Laboratory Medicine Division Medical University of Warsaw Warsaw Poland

Department of Physiology CHRU University Montpellier Vice President for Research PhyMedExp INSERM U1046 CNRS UMR 9214 Montpellier France

Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland

Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands

Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands Erasmus MC Department of Obstetrics and Gynaecology University Medical Center Rotterdam The Netherlands

Department of Pulmonary Diseases Faculty of Medicine Celal Bayar University Manisa Turkey

Department of Pulmonary Diseases Istanbul University Cerrahpasa Cerrahpasa Faculty of Medicine Istanbul Turkey

Department of Pulmonary Medicine CHU Sart Tilman and GIGA I3 Research Group Liege Belgium

Department of Pulmonary Medicine Rashid Hospital Dubai UAE

Department of Respiratory Medicine and Allergology University Hospital Lund Sweden

Department of Respiratory Medicine Hvidovre Hospital and University of Copenhagen Copenhagen Denmark

Department of Respiratory Medicine University Hospital Olomouc Olomouc Czech Republic

Department of Social Medicine Faculty of Medicine University of Crete and International Primary Care Respiratory Group Crete Greece

Departments of Internal Medicine and Pediatrics University of Tennessee College of Medicine Germantown TN USA

Dept of Otorhinolaryngology Chiba University Hospital Chiba Japan

Dept of Respiratory Medicine Ghent University Hospital Ghent Belgium

Dept of Respiratory Medicine National Institute of Diseases of the Chest and Hospital Dhaka Bangladesh

DG for Health and Social Care Scottish Government Edinburgh UK

Die Hautambulanz and Rothhaar study center Berlin Germany

Director Consortium of Pharmacies and Services COSAFER Salerno Italy

Director of Center of Allergy Immunology and Respiratory Diseases Center for Allergy and Immunology Santa Fe Argentina

Director of Department of Pharmacy of University of Naples Federico 2 Naples Italy

Division for Health Innovation Campania Region and Federico 2 University Hospital Naples Naples Italy

Division of Allergy and Clinical Immunology Department of Medicine Agency of Health ASL Salerno Santa Maria della Speranza Hospital Salerno Italy

Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel

Division of Allergy Clinical Immunology and Rheumatology Department of Pediatrics Federal University of São Paulo Sao Paulo Brazil

Division of Allergy Department of Pediatric Medicine The Bambino Gesù Children's Research Hospital Holy See Rome Italy

Division of Allergy Immunology University of South Florida Tampa FL USA

Division of Clinical Immunology and Allergy Laboratory of Behavioral Immunology Research The University of Mississippi Medical Center Jackson MS USA

Division of Immunopathology Department of Pathophysiology and Allergy Research Center for Pathophysiology Infectiology and Immunology Medical University of Vienna Vienna Austria

Division of Infection Immunity and Respiratory Medicine Royal Manchester Children's Hospital University of Manchester Manchester UK

Division of Internal Medicine Asthma and Allergy Barlicki University Hospital Medical University of Lodz Poland

Division of Respiratory and Allergic Diseases Department of Respiratory Diseases High Specialty Hospital ACardarelli Napoli Italy

EA 2991 Euromov University Montpellier Montpellier France

Ecole polytechnique Palaiseau IRBA France

EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium

ENT Department Eskisehir Osmangazi University Eskisehir Turkey

ENT Department University Hospital of Kinshasa Kinshasa Congo

Epidemiology of Allergic and Respiratory Diseases Department Institute Pierre Louis of Epidemiology and Public Health INSERM and Sorbonne Universités Medical School Saint Antoine Paris France

ERS President 2017 2018 Athens Chest Hospital 7th Resp Med Dept and Asthma Center Athens Greece

Eshelman School of Pharmacy University of North Carolina Chapel Hill NC USA

European Forum for Research and Education in Allergy and Airway Diseases Brussels Belgium

European Health Futures Forum Dromahair UK

Ezfy Lisbon Portugal

Faculty of Health Sciences and CICS UBI Health Sciences Research Centre University of Beira Interior Covilhã Portugal

Faculty of Medicine Autnonous University of Madrid Madrid Spain

Faculty of Medicine Transylvania University Brasov Romania

Farmacie Dei Golfi Group Massa Lubrense Italy

FILHA Finnish Lung Association Helsinki and Turku University Turku Finland

Finnish Meteorological Institute Helsinki Finland

Food Allergy Referral Centre Veneto Region Department of Women and Child Health Padua General University Hospital Padua Italy

Gamkrelidze National Center for Disease Control and Public Health of Georgia Tbilisi Georgia

GARD Chairman Geneva Switzerland

General Practice Nîmes France

Global Allergy and Airways Patient Platform GAAPP Vienna Austria

Hallym University College of Medicine Hallym University Sacred Heart Hospital Gyeonggi do South Korea

Health Economics and Health Technology Assessment Institute of Health and Wellbeing University of Glasgow Glasgow UK

Health Planning Unit Department of Social Medicine Faculty of Medicine University of Crete Crete Greece and International Primary Care Respiratory Group IPCRG Aberdeen Scotland

Honorary Clinical Research Fellow Allergy and Respiratory Research Group The University of Edinburgh Edinburgh UK

Hospital Civil de Guadalajara Dr Juan 1 Menchaca Guadalarara Mexico

Hospital de Clinicas University of Parana Parana Brazil

Hospital General Regional 1 Dr Carlos Mc Gregor Sanchez Navarro IMSS Mexico City Mexico

Hospital of the Hospitaller Brothers in Buda Budapest Hungary

IMIM Barcelona Spain

Immunology and Allergy Division Clinical Hospital University of Chile Santiago Chile

Immunomodulation and Tolerance Group Imperial College London and Allergy and Clinical Immunology Imperial College London London UK

Imperial College London National Heart and Lung Institute London UK

IMSS Hospital General Region 1 Dr Carlos Mc Gregor Sanchez Navarro Mexico City Mexico

IMT Mines Ales Université Montpellier Montpellier France

Independent Consultant Joensuu Finland

INSERM U 1168 VIMA Ageing and Chronic Diseases Epidemiological and Public Health Approaches Villejuif Université Versailles St Quentin en Yvelines UMR S 1168 Montigny le Bretonneux France and Charité Universitätsmedizin Berlin Humboldt Universität zu Berlin and Berlin Institute of Health Comprehensive Allergy Center Department of Dermatology and Allergy Berlin Germany

Institute for Immunological Research University of Cartagena Campus de Zaragocilla Edificio Biblioteca Primer Piso Cartagena Colombia and Foundation for the Development of Medical and Biological Sciences Cartagena Colombia

Institute for Research and Biomedical Innovation Palermo Italy

Institute of Biomedical Sciences Department of Pathology Faculty of Medicine Vilnius University and Institute of Clinical Medicine Clinic of Chest diseases and Allergology Faculty of Medicine Vilnius Lithuania

Institute of Health Policy and Management iBMG Erasmus University Rotterdam The Netherlands

Institute of Lung Health Respiratory Biomedical Unit University Hospitals of Leicester NHS Trust Leicestershire UK; Department of Infection Immunity and Inflammation University of Leicester Leicester UK

Institute of Social Medicine Epidemiology and Health Economics Charité Universitätsmedizin Berlin Berlin and Institute for Clinical Epidemiology and Biometry University of Wuerzburg and Institute of Health Resort Medicine and Health Promotion Bavarian Health and Food Safety Authority Bad Kissingen Germany

Instituto de Medicina Preventiva e Saude Publica Instituto de Saude Ambiental Centro de Estudos de Medicina Baseada na Evidência Cochrane Portugal

International Primary Care Respiratory Group IPCRG Aberdeen Scotland

iQ4U Consultants Ltd London UK

ISGlobAL Centre for Research in Environmental Epidemiology Barcelona Spain

Johns Hopkins School of Medicine Baltimore MD USA

Kronikgune International Centre of Excellence in Chronicity Research Barakaldo Bizkaia Spain

KYomed INNOV Montpellier France

Kyrgyzstan National Centre of Cardiology and Internal Medicine Euro Asian Respiratory Society Bishkek Kyrgyzstan

Laval's University Quebec QC Canada

Lead Respiratory Physician Mater Dei Hospital Malta Academic Head of Department and Professor of Medicine University of Malta Deputy Dean Faculty of Medicine and Surgery University of Medicine La Valette Malta

Life and Health Sciences Research Institute School of Medicine University of Minho Braga Portugal; ICVS 3B's PT Government Associate Laboratory Guimaraes Portugal

Lung Allergy Department at Astrid Lindgren Children's Hospital Karolinska University Hospital and Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

MACVIA France and CHU Montpellier France

Market Access Senior Manager Medicines for Europe Brussels Belgium

Medical Consulting Czarlewski Levallois and MASK air Montpellier France

Medical Faculty Skopje University Clinic of Pulmology and Allergy Skopje Republic of Macedonia

Mines ParisTech CRI PSL Research University Fontainebleau France

Municipality Pharmacy Sarno Italy

National Center for Research in Chronic Respiratory Diseases Tishreen University School of Medicine Latakia and Syrian Private University Damascus Damascus Syria

National Center of Expertise in Cognitive Stimulation Broca Hospital Paris France

National Heart and Lung Institute Imperial College London and Royal Brompton Hospital Airways Disease Section London UK

National Insitute for Health and Welfare Helsinki Finland

National Institute of Pneumology M Nasta Bucharest Romania

National Research Center Institute of Immunology Federal Medicobiological Agency Laboratory of Molecular immunology Moscow Russian Federation

Nova Southeastern University Fort Lauderdale FL USA

NRC Institute of Immunology FMBA of Russia Moscow Russia and Laboratory of Immunopathology Department of Clinical Immunology and Allergy Sechenov 1st Moscow State Medical University Moscow Russia

Observational and Pragmatic Research Institute Singapore Singapore City Singapore

Oslo University Hospital Department of Paediatrics Oslo and University of Oslo Faculty of Medicine Institute of Clinical Medicine Oslo Norway

Pediatric Allergy and Asthma Unit Hacettepe University School of Medicine Ankara Turkey

Pediatric Allergy and Immunology Unit Children's hospital Ain Shams University Cairo Egypt

Peercode BV Geldermalsen The Netherlands

Personalized Medicine Clinic Asthma and Allergy Humanitas Clinical and Research Center IRCCS Rozzano and Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

Pharmaceutical Care Unit Faculty of Pharmaceutical Sciences Ghent University Ghent Belgium

PIPA Pediatric Program on Asthma Prevention Uruguaiana Brazil

PNDR Portuguese National Programme for Respiratory Diseases Faculdade de Medicina de Lisboa Lisbon Portugal

Pneumologie et Soins Intensifs Respiratoires Centre Hôpital Cochin Hôpitaux Universitaires Paris Paris France

Pneumology and Allergy Department CIBERES and Clinical and Experimental Respiratory Immunoallergy IDIBAPS University of Barcelona Barcelona Spain

Pneumology Department Hospitais da Universidade de Coimbra Centro Hospitalar e Universitário de Coimbra Coimbra Portugal

ProAR Nucleo de Excelencia em Asma Federal University of Bahia Brasil and WHO GARD Planning Group Brazil

Public Health Aix marseille University Marseille France

Pulmonary Division Heart Institute Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo Sao Paulo Brazil

Pulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology Pisa Via Trieste 41 56126 Pisa Italy; and CNR Institute of Biomedicine and Molecular Immunology A Monroy Palermo Italy

Pulmonary Unit Department of Medical Specialties Arcispedale SMaria Nuova IRCCS AUSL di Reggio Emilia Reggio Emilia Italy

Quebec Heart and Lung Institute Laval University Quebec QC Canada

Regional Ministry of Health of Andalusia Seville Spain

Regione Piemonte Torino Italy

Research Fellow OPC Cambridge UK and Director Medscript Paraparaumu New Zealand

Rhinology Unit and Smell Clinic ENT Department Hospital Clínic; Clinical and Experimental Respiratory Immunoallergy IDIBAPS CIBERES University of Barcelona Spain

RNSA Brussieu France

Sachs' Children and Youth Hospital Södersjukhuset Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Scientific Centre of Children's Health under the PoH Russian National Research Medical University named Pirogov Moscow Russia

Scottish Centre for Respiratory Research Cardiovascular and Diabetes Medicine Medical Research Institute Ninewells Hospital University of Dundee Dundee UK

Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis MO USA

Service Immunologie et Allergie Centre Hospitalier Universitaire Vaudois Lausanne Switzerland

Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina

Serviço de Immunologia Hospital de Dona Estefânia Centro Hospitalar de Lisboa Central Lisbon Portugal and Nova Medical School Comprehensive Health Research Center Universidade Nova de Lisboa Lisboa Portugal

Sidkkids Hospitala and Institute of Health Policy Management and Evaluation Toronto Canada

Skin and Allergy Hospital Helsinki University Hospital and University of Helsinki Helsinki Finland

Sleep Unit Department of Neurology Hôpital Gui de Chauliac Montpellier Inserm U1061 Montpellier France

Sociedad Paraguaya de Alergia Asma e Inmunologı'a Paraguay

SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy

State Key Laboratory of Respiratory Diseases Guangzhou Institute of Respiratory Disease The 1st Affiliated Hospital of Guangzhou Medical University Guangzhou China

Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland

The Allergy and Asthma Institute Pakistan

The Royal National TNE Hospital University College London UK

The Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK

Tobacco Control Research Centre; Iranian Anti Tobacco Association Tehran Iran

UCIBIO REQUINTE Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto Porto Portugal

Ukrainina Medical Stomatological Academy Poltava Ukraine

Universidad Autónoma de Nuevo León San Nicolás de los Garza Mexico

Universidad Católica de Córdoba Córdoba Argentina

Universitat Pompeu Fabra Barcelona Spain

Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Germany

Université Grenoble Alpes Laboratoire HP2 Grenoble INSERM U1042 and CHU de Grenoble Grenoble France

Université Paris Sud; Service de Pneumologie Hôpital Bicêtre; Inserm UMR_S999 Le Kremlin Bicêtre France

University Clinic of Respiratory and Allergic Diseases Golnik Slovenia

University Hospital Sv Ivan Rilski Sofia Bulgaria

University of Bari Medical School Unit of Geriatric Immunoallergology Bari Italy

University of Genoa Department of Internal Medicine and IRCCS Ospedale Policlinico San Martino Genoa Italy

University of Medicine and Pharmacy Hochiminh City Vietnam

UOC Pneumologia Istituto di Medicina Interna F Policlinico Gemelli IRCCS Università Cattolica del Sacro Cuore Rome Italy and National Heart and Lung Institute Royal Brompton Hospital and Imperial College London London UK

Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium and Sun Yat sen University International Airway Research Center 1st Affiliated Hospital Guangzou China and Division of ENT Diseases CLINTEC Karolinska Institutet Stockholm and Department of ENT Diseases Karolinska University Hospital Stockholm Sweden

UPRES EA220 Pôle des Maladies des Voies Respiratoires Hôpital Foch Université Paris Saclay Suresnes France

Veneto Region Mattone Internazionale Program Venise Italy

Vilnius University Faculty of Medicine Institute of Clinical Medicine and Institute of Health Sciences Vilnius Lithuania

Woolcock Institute of Medical Research University of Sydney and Woolcock Emphysema Centre and Sydney Local Health District Glebe NSW Australia

Zobrazit více v PubMed

Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy 2014;69(10):1275-1279.

Gopal G, Suter-Crazzolara C, Toldo L, Eberhardt W. Digital transformation in healthcare-architectures of present and future information technologies. Clin Chem Lab Med. 2019;57(3):328-335.

Mesko B, Drobni Z, Benyei E, Gergely B, Gyorffy Z. Digital health is a cultural transformation of traditional healthcare. Mhealth. 2017;3:38.

Bousquet J, Chavannes NH, Guldemond N, Haahtela T, Hellings PW, Sheikh A. Realising the potential of mHealth to improve asthma and allergy care: how to shape the future. Eur Respir J. 2017;49(5): 1601966. https://doi.org/10.1183/13993003.01966-2016

Bousquet J, Ansotegui IJ, Anto JM, et al. Mobile technology in allergic rhinitis: evolution in management or revolution in health and care? J Allergy Clin Immunol Pract. 2019;7(8):2511-2533.

Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European innovation partnership on active and healthy ageing: the European geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361-362.

Bousquet J, Addis A, Adcock I, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304-323.

Bousquet J, Barbara C, Bateman E, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028-1033.

Bousquet J, Anto JM, Bachert C, et al. From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity. Eur Respir J. 2019;54(6):1901023.

Nogueira-Silva L, Martins SV, Cruz-Correia R, et al. Control of allergic rhinitis and asthma test-a formal approach to the development of a measuring tool. Respir Res. 2009;10:52.

Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160.

Bousquet J, Hellings PW, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019;143(3):864-879.

Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47.

Bousquet J, Bedbrook A, Czarlewski W, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9:16.

Courbis A-L, Murray RB, Arnavielhe S, et al. Electronic clinical decision support system for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018;48(12):1640-1653.

Bousquet J, Agache I, Aliberti MR, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA)-EIP on AHA TWINNING Reference Site (GARD research demonstration project). Allergy 2018;73(1):77-92.

Bousquet J, Arnavielhe S, Bedbrook A, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018;8:45.

Bousquet J, Devillier P, Anto JM, et al. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy 2018;73(8):1622-1631.

Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144(1):135-143.e6.

Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy 2010;65(8):1042-1048.

van der Leeuw S, van der Molen T, Dekhuijzen PNR, et al. The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts. NPJ Prim Care Respir Med. 2015;25:14107.

Azevedo P, Correia-de-Sousa J, Bousquet J, et al. Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. Prim Care Respir J. 2013;22(1):112-116.

Bousquet J, Anto JM, Annesi-Maesano I, et al. POLLAR: impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy. 2018;8:36.

Bedard A, Anto JM, Fonseca JA, et al. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air((R)) App. Allergy 2020;75:1672-1688.

Bousquet J, Farrell J, Crooks G, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy. 2016;6:29.

Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36.

Klimek L, Bergmann K-C, Biedermann T, et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: position paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int. 2017;26(1):16-24.

Recital 26-EU GDPR. EU general data protection regulation 2016/679.2016; https://doi.org/10.1111/all.14204 [Epub ahead of print]

Article 4 EU GDPR. EU general data protection regulation 2016/679 (GDPR). http://www.privacy-regulation.eu/en/article-4-definitions-GDPR.htm; 2016.

Laune D, Arnavielhe S, Viart F, et al. Application du Règlement Général sur la Protection des Données (RGPD) à une application mobile pour la rhinite et l'asthme (MASK-air). Rev Mal Resp. 2019;36(9):1019-1031.

Samreth D, Arnavielhe S, Ingenrieth F, et al. Geolocation with respect to personal privacy for the Allergy Diary app-a MASK study. World Allergy Organ J. 2018;11(1):15.

EU Medical Device regulation. 1/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. https://eur-lexeuropaeu/legal-content/EN/ALL/?uri=CELEX:32017R0745; 2017.

Caimmi D, Baiz N, Tanno LK, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017;47(12):1526-1533.

Bousquet J, Bewick M, Arnavielhe S, et al. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy 2017;72(10):1475-1484.

Bousquet J, Caimmi DP, Bedbrook A, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy 2017;72(6):857-865.

Bousquet J, Arnavielhe S, Bedbrook A, et al. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy 2018;73(2):505-510.

Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy 2018;73(9):1763-1774.

Bousquet J, VandenPlas O, Bewick M, et al. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) questionnaire using mobile technology: The MASK study. J Investig Allergol Clin Immunol. 2018;28(1):42-44.

Menditto E, Costa E, Midao L, et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK study. Clin Exp Allergy. 2019;49(4):442-460.

Bédard A, Sofiev M, Arnavielhe S, et al. Interactions between air pollution and pollen season for rhinitis using mobile technology: a MASK-POLLAR study. J Allergy Clin Immunol Pract. 2020;8(3):1063-1073.e4.

Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3.

Lourenco O, Calado S, Sa-Sousa A, Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Manag Care Spec Pharm. 2014;20(5):513-522.

Amaral L, Martins C, Coimbra A. Use of the Control of Allergic Rhinitis and Asthma Test and pulmonary function tests to assess asthma control in pregnancy. Aust N Z J Obstet Gynaecol. 2018;58(1):86-90.

Kuipers E, Wensing M, de Smet P, Teichert M. Self-management research of asthma and good drug use (SMARAGD study): a pilot trial. Int J Clin Pharm. 2017;39(4):888-896.

Sá-Sousa A, Amaral R, Morais-Almeida M, et al. Asthma control in the Portuguese National Asthma Survey. Rev Port Pneumol 2006;2015(21):209-213.

Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy in Southern Europe. (IT-2020-MC). https://clinicaltrials.gov/ct2/show/NCT03636919); 2020.

Flokstra-de-Blok B, Baretta H, Fonseca J, et al. An app to measure and improve adherence to inhaled treatment. Proc Int Conf e-Health. 2017;2017:135-139.

Kosse RC, Bouvy ML, de Vries TW, et al. mHealth intervention to support asthma self-management in adolescents: the ADAPT study. Patient Prefer Adherence. 2017;11:571-577.

Flokstra-de Blok BMJ, Baretta H-J, Fonseca JA, et al. Control of Allergic Rhinitis and Asthma Test with 1-week recall: validation of paper and electronic version. Allergy 2018;73(12):2381-2385.

Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737-745.

Burnay E, Cruz-Correia R, Jacinto T, Sousa AS, Fonseca J. Challenges of a mobile application for asthma and allergic rhinitis patient enablement-interface and synchronization. Telemed J E Health. 2013;19(1):13-18.

Kosse RC, Bouvy ML, Belitser SV, de Vries TW, van der Wal PS, Koster ES. Effective engagement of adolescent asthma patients with mobile health-supporting medication adherence. JMIR mHealth uHealth. 2019;7(3):e12411.

Gani F, Lombardi C, Barrocu L, et al. The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study. Clin Mol Allergy. 2018;16:4.

Sousa AS, Pereira AM, Fonseca JA, et al. Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal. Rev Port Pneumol (2006). 2015:pii:S2173-5115(15)00080-9

Bousquet J, Schunemann HJ, Hellings PW, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367-374.e2.

Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2019.

Sofiev M, Vira J, Kouznetsov R, Prank M, Soares J, Genikhovich E. Construction of the SILAM Eulerian atmospheric dispersion model based on the advection algorithm of Michael Galperin. Geosci Model Dev 2015;8(11):3497-3522.

Sofiev M. On impact of transport conditions on variability of the seasonal pollen index. Aerobiologia (Bologna). 2017;33(1):167-179.

Ritenberga O, Sofiev M, Siljamo P, et al. A statistical model for predicting the inter-annual variability of birch pollen abundance in Northern and North-Eastern Europe. Sci Total Environ. 2018;615:228-239.

Amaral R, Bousquet J, Pereira AM, et al. Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes. Allergy 2019;74(4):698-708.

Raciborski F, Bousquet J, Namysłowski A, et al. Correction to: Dissociating polysensitization and multimorbidity in children and adults from a Polish general population cohort. Clin Transl Allergy. 2019;9:23.

Siroux V, Boudier A, Nadif R, Lupinek C, Valenta R, Bousquet J. Association between asthma, rhinitis, and conjunctivitis multimorbidities with molecular IgE sensitization in adults. Allergy 2019;74(4):824-827.

Toppila-Salmi S, Chanoine S, Karjalainen J, Pekkanen J, Bousquet J, Siroux V. Risk of adult-onset asthma increases with the number of allergic multimorbidities and decreases with age. Allergy. 2019;74(12):2406-2416.

Bousquet J, Meltzer EO, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726-1732.

Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity. A systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274-1286.e9.

Bosnic-Anticevich S, Costa E, Menditto E, et al. ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project. Allergy 2019;74(7):1219-1236.

Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy 2019;74(11):2087-2102.

Bousquet JJ, Schünemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44.

Patella V, Florio G, Magliacane D, et al. Prevention Plans to manage climate change and respiratory allergic diseases. Innovative models used in Campania Region (Italy): the TWINNING aria implementation and the allergy safe tree decalogue. Transl Med UniSa. 2019;19:95-102.

Poole CD, Bannister CA, Andreasen JN, Andersen JS, Currie CJ. Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health Qual Life Outcomes. 2014;12:99.

Soler R, de la Hoz B, Badia X, et al. Validation of the Spanish version of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Rev Clin Esp. 2004;204(3):131-138.

Hoehle LP, Speth MM, Phillips KM, et al. Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy. 2017;31(4):235-239.

Hwang TY, Kim SK, Kim SH, Kim M. A cross sectional survey on health-related quality of life among parents of children with allergic symptoms using the EQ-5D-5L. J Asthma. 2019;56(11):1-7.

Ilyina N, Edin A, Astafieva N, et al. Efficacy of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, delivered in a single spray, for the treatment of seasonal Allergic Rhinitis: results from Russia. Int Arch Allergy Immunol. 2019;178(3):255-263.

Speth MM, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Treatment history and association between allergic rhinitis symptoms and quality of life. Ir J Med Sci. 2019;188(2):703-710.

Bousquet J, Pham-Thi N, Bedbrook A, et al. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019;11(8):3633-3642.

Bousquet J, Pham-Thi N, Bedbrook A, et al. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2). J Thorac Dis. 2019;11(9):4072-4084.

Brożek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476.

Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958.

Wallace DV, Dykewicz MS, Oppenheimer J, Portnoy JM, Lang DM. Pharmacologic treatment of seasonal Allergic Rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters. Ann Intern Med. 2017;177(12):876-881.

Bousquet J, Schünemann H, Togias A, et al. Next-generation ARIA guidelines for allergic rhinitis based on GRADE and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. https://doi.org/10.1016/j.jaci.2019.06.049. Epub 2019 Oct 15.

Calderon MA, Demoly P, Casale T, et al. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy. 2016;6:41.

Wallace DV, Dykewicz MS. Seasonal Allergic Rhinitis: a focused systematic review and practice parameter update. Curr Opin Allergy Clin Immunol. 2017;17(4):286-294.

Patel P, Salapatek AM, Tantry SK. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol. 2019;122(2):160-166.e1.

Bousquet J, Burney PG, Zuberbier T, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy 2009;64(7):969-977.

Maurer M, Metz M, Bindslev-Jensen C, et al. Definition, aims, and implementation of GA(2)LEN Urticaria Centers of reference and excellence. Allergy 2016;71:1210-1218.

Godicke V, Hundt F. Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline. Allergy 2010;65(12):1499-1505.

Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014;69(7):854-867.

Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy 2017;72(8):1156-1173.

Whitmee S, Haines A, Beyrer C, et al. Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health. Lancet 2015;386(10007):1973-2028.

Konduri N, Aboagye-Nyame F, Mabirizi D, et al. Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals. Digit Health. 2018;4:2055207618771407.

Toumi M, Remuzat C. Value added medicines: what value repurposed medicines might bring to society? J Mark Access Health Policy. 2017;5(1):1264717.

Bachert C, Bousquet J, Hellings P. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018;8:25.

Bousquet J, Illario M, Farrell J, et al. The reference site collaborative network of the European innovation partnership on active and healthy ageing. Transl Med UniSa. 2019;19:66-81.

Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet 2012;379(9822):e45-e46.

Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007;62(3):216-223.

Global Alliance against Chronic Respiratory Diseases (GARD). 9th General Meeting, 14-16 August 2014, Salvador, Brazil. WHO/NMH/MND/CPM/14.1. www.who.int. 2014.

Hellings PW, Fokkens WJ, Bachert C, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy 2017;72(9):1297-1305.

Hellings PW, Borrelli D, Pietikainen S, et al. European summit on the prevention and self-management of chronic respiratory diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2017;7:49.

Muraro A, Fokkens WJ, Pietikainen S, et al. European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015). Rhinology. 2015;53(4):303-307.

Valiulis A, Bousquet J, Veryga A, et al. Vilnius declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy. 2019;9:7.

Kotter J. Leading change. Boston, MA: Harvard Business School Press; 1996.

Ozdalga E, Ozdalga A, Ahuja N. The smartphone in medicine: a review of current and potential use among physicians and students. J Med Internet Res. 2012;14(5):e128.

Bousquet J, Anto JM, Haahtela T, Jousilahti P, Erhola M, Basagana X, et al. Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WHO), demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing. Clin Transl Allergy. 2020;10:24.

Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach

Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model